Indication
Pediatric solid tumors
1 clinical trial
1 product
Clinical trial
Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid TumorsStatus: Recruiting, Estimated PCD: 2027-08-25
Product
Biological1 clinical trial
1 product